GLP-1 Medications for Beginners: What They Are, How They Work, and How to Start

What GLP-1 Actually Is

GLP-1 stands for glucagon-like peptide-1, a hormone your small intestine releases after you eat. Your body uses this hormone to signal the pancreas to release insulin, slow how quickly food leaves the stomach, and tell the brain you are full. People with type 2 diabetes and obesity often have blunted GLP-1 responses, which contributes to both conditions.

GLP-1 medications are synthetic versions of this hormone designed to last days instead of minutes. When injected weekly (or taken as a daily pill in some formulations), they produce the same appetite-regulating and blood-sugar-lowering effects your body would produce naturally, just at a much stronger and more sustained level. The result is reduced hunger, smaller portions feeling satisfying, and better blood sugar control for people with diabetes.

Our simple GLP-1 explainer covers the biology in everyday language, and our GLP-1 medications explained article provides a deeper overview of the class.

How GLP-1 Medications Work

Three main effects explain why GLP-1 medications produce the weight loss and blood sugar improvements they do.

Appetite reduction. GLP-1 receptors in the brain regulate the feeling of fullness. Activating them sends a stronger "I'm full" signal and quiets what many patients call "food noise," the intrusive thoughts about food that drive overeating. Our guide on how GLP-1s change your appetite signals explains the mechanism in detail, and the GLP-1 and appetite article covers what to expect day-to-day.

Slower digestion. Food moves through your stomach more slowly, which means you feel fuller longer after meals and tend to eat less at the next one. This is also why some side effects (nausea, reflux) happen; the same mechanism that helps with appetite also changes digestion.

Insulin regulation. GLP-1 medications prompt your pancreas to release insulin when blood sugar rises and reduce the liver's glucose production. For patients with type 2 diabetes, this produces major A1C improvements without the hypoglycemia risk of older diabetes drugs.

The combined effect for most patients is eating less without feeling deprived, losing weight gradually over several months, and, if they have diabetes, seeing significantly better blood sugar control. For a more technical breakdown, our article on how Ozempic works walks through the pharmacology.

Who Qualifies for a GLP-1 Prescription

Most licensed physicians follow the same general clinical criteria when evaluating patients for GLP-1 therapy.

For weight management (Wegovy, Zepbound):

• BMI of 30 or higher, or
• BMI of 27 or higher with at least one weight-related condition (type 2 diabetes, hypertension, high cholesterol, sleep apnea, cardiovascular disease)

For type 2 diabetes (Ozempic, Mounjaro, Rybelsus):

• Confirmed type 2 diabetes diagnosis, typically with an A1C of 6.5% or higher

Not suitable candidates include people with:

• Personal or family history of medullary thyroid carcinoma or MEN 2 syndrome
• Active pancreatitis or severe gastrointestinal conditions like gastroparesis
• Pregnancy or active attempt to conceive (discuss timing with your physician)
• Severe allergic reactions to any GLP-1 medication

Your physician will confirm your eligibility through a medical history review, baseline labs, and a discussion of your goals. If you are curious about your starting point, our BMI calculator gives you a reference number, though BMI is one factor among several that your physician will consider.

What to Expect: First Week and First Month

Knowing what a normal starting experience looks like helps separate expected adjustments from genuine problems.

Week 1: You will start at the lowest available dose (0.25 mg for semaglutide, 2.5 mg for tirzepatide). This starting dose is deliberately subtherapeutic; its main purpose is to let your body adjust to the medication with minimal side effects. Most patients notice reduced appetite within 3 to 7 days. Mild nausea, fatigue, or constipation may appear. Weight loss in week 1 is usually minimal (1 to 2 pounds, much of which is water).

Weeks 2 to 4: Appetite reduction becomes more pronounced. Meals feel smaller and you think about food less. Side effects, if any, typically peak around day 3 to 5 after each injection, then fade. Our semaglutide time to work guide explains the typical onset timeline.

Month 1: You should have completed one full cycle at the starting dose and be moving to the next dose level (0.5 mg semaglutide, 5 mg tirzepatide). Weight loss by the end of month 1 is typically 1 to 3% of body weight. For someone at 220 pounds, that works out to 2 to 7 pounds. This is slower than social media often suggests, but consistent with what clinical trials showed.

The titration schedule. Most patients move up to the next dose every 4 weeks, reaching therapeutic levels around month 3 or 4. This is when weight loss typically accelerates. Our GLP-1 titration guide explains why the slow climb matters and when it is appropriate to pause or hold at a dose.

What to prioritize in the first month: Hydration, protein intake, and not skipping meals even when you are not hungry. Our protein on GLP-1 guide explains why this matters for muscle preservation and long-term results.

How to Get Started

For most patients, the path from "considering it" to "actually taking the medication" follows four steps.

Step 1: Evaluation

A licensed physician reviews your medical history, current medications, height and weight, and any qualifying conditions. This can happen in person or through a legitimate telehealth platform. The evaluation should be thorough; be skeptical of any provider that approves you in under two minutes with no medical questions.

Step 2: Baseline labs

Most physicians will order baseline labs including a comprehensive metabolic panel, lipid panel, A1C, and thyroid function before prescribing. Our GLP-1 blood tests guide covers exactly what should be checked.

Step 3: Prescription and delivery

Once approved, your medication ships to you (telehealth) or goes to your local pharmacy. Your physician provides instructions on how to inject, where to inject, and how to store the medication. Our Ozempic injection guide covers the practical steps.

Step 4: Ongoing monitoring‍

Most programs include follow-up visits every 4 to 8 weeks to review progress, adjust dose, and address any side effects. This ongoing physician oversight is critical; it is what separates legitimate GLP-1 therapy from unsupervised online shortcuts.

Our full how-to-get-GLP-1 page walks through each of these steps in more detail, including what to expect from the initial consultation.